HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
MGX holding history
Metagenomi Therapeutics, Inc.
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding MGX, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
MGX overviewAll 13F holders of MGXFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.00% | −150,699−100.0% | Sold out |
| Q1 2025 | 150,699 | $204.95K | 0.01% | −627,069−80.6% | Reduced |
| Q4 2024 | 777,768 | $2.81M | 0.10% | 00.0% | Unchanged |
| Q3 2024 | 777,768 | $1.69M | 0.04% | 00.0% | Unchanged |
| Q2 2024 | 777,768 | $3.17M | 0.08% | 00.0% | Unchanged |
| Q1 2024 | 777,768 | $8.21M | 0.18% | +777,768 | New |